NCT00274807View on ClinicalTrials.gov

Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia

PHASE2CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

June 30, 2001

Primary Completion Date

April 30, 2007

Study Completion Date

May 31, 2008

Conditions
Leukemia
Interventions
BIOLOGICAL

filgrastim

DRUG

cytarabine

DRUG

etoposide

DRUG

mitoxantrone hydrochloride

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

The Cleveland Clinic

OTHER

NCT00274807 - Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia | Biotech Hunter | Biotech Hunter